Premolar Extractions for Obstructive Sleep Apnea in Children with Overjet
Launched by MOHAMED BAZINA · Jun 22, 2021
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how removing certain teeth, called upper premolars, affects children with a condition called obstructive sleep apnea. This condition causes breathing problems during sleep, which can lead to poor sleep and health issues. The researchers want to see if taking out these teeth helps improve the sleep quality of children aged 10 to 15 who have a specific dental issue known as excessive overjet, which means their front teeth stick out too much.
To join the study, children must be between 10 and 15 years old and already registered with an orthodontist for treatment. They should not have serious breathing problems or allergies that could affect their nose or breathing. Participants will undergo sleep studies before and after their orthodontic treatment to measure any changes in their sleep apnea symptoms. This trial is currently recruiting, and it's important for families to know that taking part in this study could help improve understanding of how dental treatments impact sleep health in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 10-15 years old
- • registered orthodontic patients
- • able to undergo routine orthodontic care and are registered to obtain an orthodontic appliance in the future.
- • do not have a high care need
- • no known hypercapnia or hypoventilation
- • no known allergies or nose blockages
- • diagnosed as Class II Division I (=6mm of overjet) and bilateral Class II half cusp or unilateral Class II full cusp.
- Exclusion Criteria:
- • known hypercapnia or hypoventilation
- • patients with hypertrophic tonsils and adenoids
- • patients with allergies or nose blockages that interfere with breathing
- • patients who are not registered as orthodontic patients at research sites deemed acceptable to undergo routine orthodontic care
About Mohamed Bazina
Mohamed Bazina is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a strong focus on innovative therapeutic solutions, Bazina oversees the design, implementation, and management of clinical trials across various therapeutic areas. His expertise in regulatory compliance, patient safety, and data integrity ensures that all trials are conducted to the highest ethical standards. By fostering collaboration among researchers, healthcare professionals, and stakeholders, Mohamed Bazina aims to contribute significantly to the development of safe and effective treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials